Skip to main content
Springer logoLink to Springer
. 2022 Dec 9;482(2):357. doi: 10.1007/s00428-022-03474-6

Correction to: External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme

Riziero Esposito Abate 1, Melanie H Cheetham 2, Jennifer A Fairley 3, Raffaella Pasquale 1, Alessandra Sacco 1, Wolstenholme Nicola 2, Zandra C Deans 3, Simon J Patton 2, Nicola Normanno 1,
PMCID: PMC9931820  PMID: 36482100

Correction to: Virchows Archiv

10.1007/s00428-022-03444-y

In the original published version of the above article contained incorrect Table legend. The Table 2 with correct legend is as follows:

Table 2.

Next Generation Sequencing panels used for TMB test by participating laboratories

Panel N° of laboratories
Oncomine Tumor Mutation Load 6
Custom panel 5
TruSight Oncology 500 4
Oncomine Comprehensive Assay Plus 3
SureSelect XT-HS 1
Twist Human Exome plus RefSeq 1
IDT xGen Pan-Cancer Panel v2.4 1
Oncomine Comprehensive Cancer 1
Nimblegen SeqCap EZ MedExome 1

The original article has been corrected.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Virchows Archiv are provided here courtesy of Springer

RESOURCES